Gender Differences in Diabetes and IGT: How Metabolism Varies in Males and Females

Last Updated: November 15, 2025
Estimated reading time: ~7 minutes
Word count: 1572

While metabolic diseases like diabetes affect all people, they do not affect them equally. There are significant Gender Differences in Diabetes and its precursor state, Impaired Glucose Tolerance (IGT), that have profound implications for screening, diagnosis, and treatment. This post analyzes key data from a doctoral thesis to compare and explain these variations. By the end, you will be able to analyze how factors like BMI, age of onset, and glycemic control present differently in males and females, satisfying the search intent to understand these critical distinctions.

• Females in the study generally exhibited a higher Body Mass Index (BMI) than males.
• In the pre-diabetic (IGT) stage, males were significantly older on average than females.
• Fasting Plasma Glucose (FPG) levels were significantly higher in diabetic males compared to diabetic females.
• Despite these differences, many core thyroid hormone parameters did not show significant variation between genders within the same glycemic group.
• Understanding these gender-specific patterns is crucial for effective public health strategies and personalized medicine.

Gender-Based Differences in Metabolic Disease

Demographics, Age, and BMI: The Initial Divergence

The very first indicators of metabolic disease—demographics and body composition—show clear differences between males and females. This study found that while the overall age for diabetic subjects was matched, the pathway to get there, particularly through the pre-diabetic IGT stage, varied significantly by gender.

“In the IGT group the mean age of males and female was 55.09±1.39 years and 47.62±1.28 years, respectively; the gender difference was significant (P<0.05) (Table 2).” (Farasat, c. 2008, p. 45).

This is a striking finding: females in the IGT group were, on average, more than seven years younger than their male counterparts. This suggests females may enter this high-risk pre-diabetic state at an earlier age. Concurrently, the study consistently found that Body Mass Index (BMI), a key risk factor for insulin resistance, was significantly higher in females across the board compared to males. This combination of earlier onset of IGT and higher BMI in females points to a distinct gender-specific risk profile.

Student Note / Exam Tip: For data analysis questions, remember two key demographic differences from this study: males were older in the IGT group, while females had a higher BMI across most groups.

Professor’s Insight: The higher BMI in females, particularly in South Asian populations, combined with an earlier entry into the IGT state, is a critical public health concern. It suggests that the window for preventative intervention in women may need to start earlier than in men.

Biochemical and Hormonal Profiles: A Gendered Comparison

Beyond demographics, the study drilled down into the specific biochemical and hormonal differences between males and females within the control, IGT, and diabetic groups. While some parameters showed no statistical difference, others, particularly those related to glucose control, were distinct.

“Diabetics between males (mean value of 176.48±4.73 mg/dl) and females (mean value of 189.30±4.42) (P<0.05) (Fig.3; Table 1).” (Farasat, c. 2008, p. 52).

Interestingly, while females with diabetes had higher FPG than males overall in one part of the analysis, detailed comparison in another (Table 3) showed diabetic males had significantly higher fasting glucose than diabetic females. This highlights the complexity of the data. However, the finding that diabetic females had significantly lower insulin levels than diabetic males (Table 11) is also crucial. This may suggest different patterns of β-cell exhaustion between the sexes once diabetes is established. In contrast, most thyroid hormone levels (TT3, TT4, TSH) and insulin resistance (HOMA-IR) did not show statistically significant differences between genders within the same disease category, indicating that while the risk factors and presentation may differ, the core underlying pathology is shared.

Student Note / Exam Tip: A key point is that while risk factors like BMI differ, the core measure of insulin resistance (HOMA-IR) was not significantly different between men and women in the same group, suggesting a similar degree of cellular dysfunction.

Fig: Comparison of key biochemical parameters in diabetic males and females (t-test).

Variable (Diabetic Group)	Male (n=153)	Female (n=225)	P-value
Age (years)	53.60 ± 0.85	49.48 ± 0.75	0.056 N.S
BMI (kg/m²)	26.12 ± 0.36	29.11 ± 0.24	0.065 N.S
FPG (mg/dl)	176.58 ± 4.73	189.30 ± 4.42	0.045*
Insulin (μIU/ml)	25.94±0.83	21.10±1.09	0.01*

Note: Data from Table 3 & 11. N.S = Non-significant. The significance of FPG may vary based on the specific cohort analyzed within the thesis.

Professor’s Insight: The lower insulin levels in diabetic females despite similar levels of insulin resistance could be clinically significant. It may imply that female pancreatic β-cells are more susceptible to the damaging effects of chronic hyperglycemia and glucotoxicity, leading to a faster decline in function once diabetes develops.

Implications for Disease Progression and Glycemic Control

The observed gender differences have important implications for how we understand and manage the progression of metabolic disease. The pattern of higher BMI in females and potentially different rates of β-cell decline suggests that “one-size-fits-all” approaches may be suboptimal.

“On the whole the data reflected that in both the IGT and diabetic groups, females were younger as compared to the males (P<0.05). The presence of a higher FPG and a higher BMI was observed in females as compared to the males (P<0.05).” (Farasat, c. 2008, p. 53).

The fact that females present with IGT at a younger age and with higher BMI suggests that factors like hormonal changes (e.g., post-menopause), lifestyle, and body fat distribution may play a more pronounced role in accelerating their disease risk. Glycemic control, as measured by HbA1c, was also noted to be poor in both genders in the diabetic groups, but the drivers and the rate of decline could be influenced by these gender-specific factors. This emphasizes the need for gender-stratified data in clinical trials and public health research to develop more effective and targeted interventions.

Student Note / Exam Tip: For an analytical essay, argue that these gender differences are not just statistical curiosities; they are clinically relevant factors that should inform personalized risk assessment and treatment strategies.

Professor’s Insight: This research underscores the importance of disaggregating data by sex in all metabolic research. Averaging data from males and females can mask these critical differences and lead to flawed conclusions about disease mechanisms and risk factors.

This section has been reviewed and edited by the Professor of Zoology editorial team. All content, except for direct thesis quotes, is original work produced to support student education.

Real-Life Applications

• Gender-Specific Screening Guidelines: Public health initiatives could recommend earlier screening for pre-diabetes (IGT) in women, especially those with a high BMI, given their earlier average age of onset in this study.
• Personalized Weight Management: Weight management advice for preventing diabetes may need to be tailored, recognizing that females in this population had a higher BMI at all stages of the disease.
• Tailored Patient Education: Educational materials for patients can be designed to address gender-specific risks and challenges in managing diabetes and metabolic health.
• Clinical Trial Design: Researchers designing clinical trials for new diabetes drugs should ensure adequate representation of both genders and plan for gender-stratified analysis to detect different responses to treatment.

For exams: Highlighting how these findings impact real-world public health policy and clinical practice demonstrates an ability to translate research into application.

Key Takeaways

• Significant gender differences exist in the presentation of IGT and Type 2 Diabetes.
• Females with IGT were, on average, significantly younger than males with IGT.
• Females across the study groups generally had a higher BMI than their male counterparts.
• Biochemical markers like fasting glucose and insulin levels showed significant differences between diabetic males and females.
• Core measures of thyroid function (TSH, TT4) and insulin resistance (HOMA-IR) were largely similar between genders within the same disease group.

MCQs

1. (Easy) According to the study’s findings, which group had a significantly higher Body Mass Index (BMI) on average?
   A) Males
   B) Females
   C) Both were equal
   D) The study did not measure BMI Correct: B.
   Explanation: The thesis consistently reports that females had a higher BMI compared to males in the studied population across different glycemic states.
2. (Moderate) In the Impaired Glucose Tolerance (IGT) group, what was the significant difference in age between genders?
   A) Females were significantly older than males.
   B) Both genders were the same age.
   C) Males were significantly older than females.
   D) Age was not a significant factor. Correct: C.
   Explanation: The study found that males in the IGT group were significantly older (mean age ~55 years) than females in the same group (mean age ~47 years).
3. (Challenging) Despite significant differences in BMI and age of IGT onset, which key metabolic parameter did NOT show a statistically significant difference between males and females within the diabetic group?
   A) Fasting Plasma Glucose (FPG)
   B) Insulin Resistance (HOMA-IR)
   C) Serum Insulin
   D) All parameters were different Correct: B.
   Explanation: While other markers varied, the calculated Insulin Resistance (HOMA-IR) was not significantly different between diabetic males and females (Table 11), suggesting the degree of cellular resistance was comparable despite different physical presentations.

FAQs

• Why might women develop IGT at a younger age?
  This could be due to a combination of factors including differences in body fat distribution (more visceral fat), hormonal influences throughout life, and potentially different lifestyle factors.
• Do these findings apply to all populations?
  This study was conducted on a local population in Pakistan. While the findings are significant, patterns of gender difference in diabetes can vary between different ethnic groups and geographic regions.
• Why is higher BMI a risk factor for diabetes?
  Excess adipose (fat) tissue, especially around the abdomen, releases inflammatory substances and free fatty acids that can interfere with insulin signaling, leading to insulin resistance.
• Are there differences in diabetes complications between genders?
  Yes. Globally, women with diabetes have a higher risk of heart disease and are more likely to have poorer outcomes after a heart attack than men with diabetes.

Lab / Practical Note

When conducting population-based research, it is an ethical and scientific imperative to collect demographic data, including sex/gender. Analyzing data without stratifying by these variables can lead to conclusions that are only valid for the majority subgroup (e.g., males) and may result in health recommendations that are inappropriate for other groups.

• Sex and Gender Differences in Diabetes and Diabetic Complications (NCBI)
• Diabetes in women – an overview (ScienceDirect)

Thesis Citation: Farasat, T. (c. 2008). Molecular Mechanisms of Thyroid Status in Glycemic Anomalies of Local Population. Thesis for Doctor of Philosophy in Zoology, Supervisor Prof. Dr. Muhammad Naeem Khan, University of the Punjab, Lahore. Pages used for this summary: 45, 48, 50-53, 63-64, 74. Note: The exact publication year is unlisted and is estimated. Placeholder tokens were removed during the editing process.

The author and their institution are invited to contact us at contact@professorofzoology.com to share an official abstract or provide any corrections to this educational summary.

---

Author: Tasnim Farasat, Ph.D. Scholar, Department of Zoology, University of the Punjab, Lahore.
Reviewer: Abubakar Siddiq

Disclaimer: Intended for academic and student audiences, this article interprets scientific research and does not provide medical advice. Consult a healthcare professional for health issues.

Note: This summary was assisted by AI and verified by a human editor.